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PENYEDIAAN DAN PENCIRIAN TERBITAN KITOSAN TERLARUT AIR 
DENGAN BEBERAPA AKTIVITI BIOLOGI 
ABSTRAK 
Tujuan penyelidikan ini adalah untuk mensintesis terbitan kitosan larut air yang baru, 
serta mengkaji sifat fizik dan sifat kimia, mereka disamping sifat antibakteria dan 
antikanser. Justeru, 14  terbitan kitosan disintesis dengan julat berat molekul yang 
luas (daripada 0.56 hingga 220 kDa). Pelbagai kumpulan berfungsi, iaitu fenilanilina, 
benzena-1,3-diol, metilfenol, 8-hidroksikuinolina, 2-aminopiridina, (bis(2-kloroetil) 
eter, 4,7,10-trioksa-1,13-tridekanadiamina, disiandiamida, akrilamida dan poli(1-
vinilpirolidon-ko-2-dimetilaminoetilmetakrilat  telah digunakan untuk menghasilkan  
kitosan yang terubahsuai. Terbitan ini dicirikan dengan menggunakan pelbagai  
teknik alatan seperti  spektroskopi   inframerah transformasi Fourier (FT-IR), 
spektroskopi resonan magnetik nuklear (NMR) (proton dan karbon-13), analisis 
termogravimetrik  (TGA) dan kalorimetri pengimbasan pembezaan (DSC).  
Kebanyakan terbitan ini menunjukkan keterlarutan dalam keadaan neutral dan 
berasid. Terbitan kitosan menunjukkan darjah pendeasetilan yang lebih rendah 
daripada kitosan, dan keadaan hablur kitosan bertukar kepada amorfus selepas 
kumpulan berfungsi diperkenalkan. Kebanyakan terbitan juga menunjukkan sifat 
pendarcahaya yang menarik.  Semua terbitan mempunyai kesan antiproliferatif yang 
berbeza terhadap tiga jalur kanser apabila ujian in vitro dijalankan, iaitu kanser 
prostat, kolon dan kanser payudara pada pH neutral. Terbitan 4,7,10-trioksa-1,13-
tridekanadiamina kitosan menunjukkan ketoksikan yang rendah terhadap sel kanser 
payudara dengan  IC50 = 109.8 µg mL
-1
. Bis(2-kloroetil) eter kitosan menunjukkan 
aktiviti yang signifikan terhadap kanser payudara MCF-7 dengan IC50 = 57.25 µg 
xxv 
 
mL
-1
.
 
8-Hidroksikuinolina kitosan menunjukkan kesan antiproliferatif yang amat 
tinggi terhadap jalur sel kanser yang diuji, iaitu jalur sel kanser prostat PC3 dengan 
IC50 = 12.11 µg mL
-1
, jalur sel kanser payudara MCF-7 dengan IC50 = 14.18 µg mL
-1
 
dan jalur sel kanser kolon HCT-116 dengan IC50 = 79.21 µg mL
-1
. Sifat antibakteria 
terhadap bakteria gram-negatif, iaitu  E. coli dan bakteria gram-positif, iaitu S. 
aureus menunjukkan. Kepekatan Perencatan Minimum (MIC) pada 1000 µg mL
-1
. 
Namun demikian,  kebanyakan terbitan kitosan menunjukkan nilai MIC yang lebih 
rendah, iaitu dari 500 hingga 62.5 µg mL
-1
. 
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PREPARATION, CHARACTERIZATION AND SOME BIOLOGICAL 
ACTIVITIES OF WATER SOLUBLE CHITOSAN DERIVATIVES 
ABSTRACT 
The aim of this research is to synthesise novel water-soluble chitosan derivatives and 
to investigate their physical, chemical as well as antibacterial and anticancer 
properties. Thus, fourteen chitosan derivatives were synthesised with a wide range of 
molecular weights (from 0.56 to 286 kDa). Various functional groups, i.e. 
phenylaniline, benzene-1,3-diol, methylphenol, 8-hydroxyquinoline, 2-
aminopyridine, (bis(2-chloroethyl)ether, 4,7,10-trioxa-1,13-tridecanediamine, 
dicyandiamide, acrylamide, poly(1-vinylpyrrolidone-co-2-dimethylaminoethyl 
methacrylate) were used to produce the modified chitosans. These derivatives were 
characterized using various techniques such as Fourier transform infrared 
spectroscopy (FT-IR), nuclear magnetic resonance spectroscopy (NMR) (proton and 
carbon-13) elemental analysis, thermogravimetric analysis (TGA) and differential 
scanning calorimetry (DSC).  Most of these derivatives showed remarkable solubility 
in neutral and acidic conditions. The chitosan derivatives showed lower degree of 
deacetylation than chitosan, and the crystalline state for chitosan was changed to 
amorphous after the introduction of the functional groups. Most of the derivatives 
also showed interesting luminescent properties. All derivatives have different 
antiproliferative effect against three cancer lines when tested in vitro namely 
prostate, colon and breast cancer at neutral pH. The 4,7,10-trioxa-1,13-
tridecanediamine chitosan derivative exhibited mild cytotoxicity against breast 
cancer cell with IC50 = 109.8 µg mL
-1
. Bis(2-chloroethyl) ether chitosan showed 
significant activity against breast cancer MCF-7 with IC50 = 57.25 µg mL
-1
.
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Hydroxyquinoline chitosan exhibits the highest antiproliferative effect against the 
tested cancer cell lines i.e., prostate cancer cell line PC3 with IC50 = 12.11 µg mL
-1
, 
breast cancer cell line MCF-7 with IC50 = 14.18 µg mL
-1
 and colon cancer cell line 
HCT-116 with IC50 = 79.21 µg mL
-1
. Antibacterial properties against gram-negative 
bacteria namely E. coli and gram-positive bacteria namely S. aureus showed 
Minimum Inhibitory Concentration (MIC) at 1000 µg mL
-1 
for chitosan. However, 
most of the chitosan derivatives showed lower MIC values namely from 500 to 62.5 
µg mL
-1
.
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CHAPTER 1 
INTRODUCTION 
 
1.1 Chitosan 
Chitosan is a natural polysaccharide polymer that is obtained from the partial 
deacetylation of chitin (Figure 1.1.a) [1]. Chitosan are high-molecular-weight and 
linear heteropolysaccharide compound that composed of a β (1→4) linked to two 
monosaccharides, N-acetyl-D-glucosamine and D-glucosamine. The structure of 
chitosan can be observed in Figure 1.1.b. Chitosan consists of three types of reactive 
functional groups, which are an amino group at C-2, primary hydroxyl group at C-3 
and secondary hydroxyl at C-6 positions, respectively [2, 3]. 
 
 
Figure 1.1 Structures of (a) chitin and (b) chitosan  
 
In 1859, Rouge discussed the deacetylated form of chitosan by subjecting 
chitin to alkali treatment [4-6]. The interest on the use of chitosan has continued 
between 1930s to early 1940s [7]. In 1960s, a number of Asian nations such as 
Japan, Korea, Singapore, Taiwan, and Thailand were able to achieve ample amount 
of research that focused on better understanding of chitin and chitosan materials, and 
covering the whole spectrum of research from better production to the purification 
methods [5]. In 1970s, there was a resurgence of interest in chitosan [5, 6]. China has 
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joined these researchers and become an important producer of chitin and chitosan in 
Asia [5]. In the last few decades, chitosan has shown as a potential source of 
bioactive material and abundant of applications [8]. 
 
1.1.1 Production of Chitosan 
The production of chitosan starts from the isolation of chitin from shells of 
crustaceans wastes of the seafood industries such as (shrimp, crab, and crawfish) 
(Table 1.1) [9,10]. These natural sources produced chitin amounting to a hundred 
billion tons each year [11]. 
 
Table 1.1: Contents of chitin from natural resources as reported by Kurita [10] 
Source Chitin (%) 
Crab cuticle 15–30 
Shrimp cuticle 30-40 
Krill cuticle 20–30 
Squid pen 20–40 
Clam/oyster shell 3-6 
Insect cuticle 5–25 
Fungi cell wall 10-25 
 
These wastes from the seafood industries composed of lipids as primary structural 
components, protein, inorganic salts, and chitin. They are initially crushed and filled 
as powder to initiate further heterogeneous processes (Figure 1.2) [9]. 
In the first approach, 5 % sodium hydroxide was added to the shells to 
dissolve the various proteins, leaving behind chitin, lipids and calcium salts (mainly 
as CaCO3). Then the mixture was treated with 30 % hydrochloric acid to dissolve the 
calcium salts (demineralization). This step also hydrolyzes the lipids, dissolves other 
minor inorganic constituents and produces chitin. The obtained chitin is hydrolyzed 
at 100 °C in the presence of 50 % sodium hydroxide solution to produce chitosan [9]. 
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In the second approach, 5 % hydrochloric acid was added to the shells 
powder to remove calcium salts. This step followed high-temperature (110 °C) 
treatment with 40 % sodium hydroxide to remove protein and lipids. During the 
treatment, a concomitant hydrolysis of acetamide groups in chitin has taken place, 
resulting in the formation of chitosan [1, 9]. 
 
  
 
Figure 1.2 Isolation of chitin and synthesis of chitosan as reported by Olteanu [9] 
 
1.1.2 Properties of Chitosan     
The characteristics of chitosan and the final product performance are affected 
by many conditions such as the type and concentration of reagents, the time and the 
reaction temperature throughout the processing. The relevant parameters of the 
product are degree of deacetylation (DD) and molecular weight that influences the 
solubility, rheological and physical properties [8]. The variation in commercial 
chitosan grades is due to the difference in the DD and molecular weight. However, 
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the improvements in chitosan characteristics can be achieved through modifications 
of the DD and the molecular weight. For example, the value of DD can be decreased 
by deacetylation [12, 13] while the molecular weight can be reduced by acidic or 
enzymatic depolymerization [14, 15]. 
 
1.1.2.1 Molecular Weight 
Molecular weight directly influences the chemical, physical and biological 
properties of chitosan, such as viscosity, solubility, adsorption on solids, elasticity 
and tear strength [8]. The effect of chitosan for biomedical applications comes not 
only from their chemical structure but also comes from the molecular weight [15]. It 
was observed that the crystallinity of chitosan increased with decrease in molecular 
weight [8]. The average molecular weight can range from 50 to 2000 kDa, depending 
on the preparation processes and the source [16, 17]. 
 
1.1.2.2 Degree of Deacetylation 
The degree of deacetylation (DD) can be used to specify the variation of 
acetyl content for this family of polymer. The names chitin and chitosan correspond 
to acetyl content that is measured by the DD [8]. Deacetylation is the removal of 
acetyl groups from the chitin molecular chain, leaving behind amino groups (NH2). 
Increasing the number of this amine group in chitosan requires repeated alkaline 
treatment to achieve high deacetylation (can be up to >90% [13]). Increasing the 
number of amine groups can also be done by increasing the temperature or the 
strength of the alkaline solution during the deacetylation reaction [8]. Its property is 
dependent on the ratio of 2-acetamido-2-deoxy-D-glucopyranose to 2-amino-2-
deoxy-D-glucopyranose in the structural units and the content of free amino groups 
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and can be used to differentiate between chitin and chitosan [1]. If the percentage of 
2-amino-2-deoxy-D-glucopyranose units in the component is more than 50%, it is 
termed chitosan. Conversely, when the percentage of 2-acetamido-2-deoxy-D-
glucopyranose units is higher, the term chitin is used [7, 18].  Nevertheless, in 2002 
and Tommeraas et al. [19] suggested that chitin with DD of 60% and above to be 
known as chitosan. 
The degree of crystallinity in chitin and chitosan is a function of the degree of 
deacetylation. High DD will result in chitosan with high crystallinity [16]. Solubility 
in acidic solution and the crystallinity of chitosan shows a strong association with the 
value of DD [20]. Chitosan with different ranges of DD (40 to 98%) has been 
commercially produced [16, 17]. 
 
1.1.2.3 Solubility of Chitosan 
Chitosan is a weak base, which is insoluble in water, alkali or aqueous 
solutions at pH value higher than 7 and also in most organic solvents. Chitosan has 
the ability to dissolve in certain inorganic and organic acids such as hydrochloric, 
nitric, acetic , phosphoric, propionic, succinic, tartaric, lactic, citric and formic acids 
at certain pH values after prolonged stirring [8, 16, 21-23]. Chitosan is insoluble in 
sulphuric acid because they can react to form a white crystalline solid of chitosan 
sulphate [23]. The variation of chitosan solubility in acids depends on the pKa of 
these acids and their concentrations [8, 20].  
The solution viscosity in all solvent system is affected by polymer 
concentration, temperature, counter-ion concentration and pH [8]. For example, 
solution at pH below 4 postive charge of protonated amino group in chitosan causing 
to enhance the electrostatic repealing between charged groups of similar charge, 
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leading to promotion of swelling of the chitosan network [20]. While solvent with 
pH of 5.2 generates chitosan with the unstable structure because the free amino 
groups compose intermolecular hydrogen bonds with the oxygen in an excess of 
NaOH [24]. For solution at pH value higher than 6.5, which is roughly equal to the 
pKa of chitosan amino group, the phase separation happens with the increase in 
aggregate size and the chitosan obtained coagulates and is recovered as an 
amorphous solid [20, 25]. The free amino (NH2) groups in chitosan chain forms 
conformational features through intramolecular and/or intermolecular hydrogen 
bonding and make it a cationic polyelectrolyte (pKa ≈ 6.5),  making it soluble in 
acidic solutions below pH ~ 6.5 [20]. 
The major limitation of chitosan comes from the poor solubility at 
physiological pH (7.4), especially for biomedical applications where it is insoluble 
and ineffective as an absorption enhancer [26]. There are many improvements of 
chitosan solubility such as by reducing the molecular weight [14, 15, 23]. Different 
chemical modification techniques that involve introducing a hydrophilic functional 
group such as polyethylene glycol (PEG) have been employed in previous studies to 
produce water-soluble derivatives of chitosan [16, 19, 20, 23, 26, 27]. The recently 
good water solubility of modified chitosan has attracted the attention of many 
researchers such as O-quaternary ammonium N-acyl thiourea chitosan [7]. 
 
1.1.2.4 Viscosity 
The viscosity of chitosan is an important factor in determining its commercial 
and biological applications. The viscosity of chitosan is proportional to the molecular 
weight and conversely with the demineralization time [28]. Moreover, it is affected 
by other factors during production processes such as the degree of deacetylation, 
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concentration of the solution, ionic strength, pH, and temperature. The intrinsic 
viscosity of chitosan depends on the degree of ionization more than the ionic strength 
[29]. This is confirmed by the variation of chitosan viscosity in acids such as in 
acetic acid. The viscosities increases with decreasing pH, In case of decrease pH by 
using HCl causes to lower the viscosity. It means depend of kind of acid used to 
decrease the pH. Bough et al. [29] and Moorjani et al. [28] have reported that the 
production of chitosan with 3% NaOH or acetone considerable decreases the 
viscosity of the final chitosan products. They concluded that chitosan viscosity is 
strongly affected by physical treatments such as grinding, heating, autoclaving and 
ultrasonication and showed that the decrease in viscosity with an increase in 
treatment time and temperature [30]. 
Bough et al. [29] investigated the effect of particle size on the viscosity of 
chitosan. They found that smaller particle size (1 mm) resulted in chitosan products 
of both higher viscosity and molecular weight than those of either 2 or 6.4 mm 
particle size, because the larger particles need more swelling time. 
 
1.1.2.5 Biological Properties of Chitosan   
Chitosan and its derivatives have appealing biological properties such as low 
toxicity, biodegradability, and biocompatibility. These properties lead to commercial 
production of chitosan and its derivatives for medical, pharmaceutical and industrial 
applications [31, 32, 33]. 
 
1.1.2.5.1 Biodegradability  
Biodegradability is one of the most essential and valuable properties of 
chitosan and its derivatives. Usually, non-toxic oligosaccharides lengths can be 
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obtained from the biodegradation of chitosan that can be generated by using several 
techniques such as physical, enzymatic and chemical methods. Physical techniques 
such as ozone treatment and ultraviolet radiation accelerate the degradation of 
chitosan [34]. Enzymatically, chitosan can be degraded in vitro, by several non-
specific enzymes such as lysozymes, pepsin, papain, cellulase, pectinase, proteases 
and lipases that are found in mammals [35, 36]. The oligosaccharides can be 
subsequently incorporated into glycosaminoglycans and glycoproteins metabolic 
pathways [16]. It believed that chitosan degrades invertebrates mostly by lysozyme 
and bacterial enzymes inside the colon [37]. 
Chitosan degradation is affected by the DD value and the distribution of their 
acetyl groups. The DD value that controls the degree of chitosan crystallinity is 
inversely proportional to degradation kinetics while reducing of acetyl groups or 
their homogeneous distribution caused very low rates of enzymatic degradation [38, 
39]. The association of chitosan degradation and the DD value has been investigated 
in several studies, and all of them obtained the same inversely proportional 
relationship [12, 40, 42]. In 2005, Kofuji et al. [41] studied the effect of enzymes on 
chitosan degradation. They considered various chitosans viscosity in the presence of 
lysozyme solutions; finally they reported that chitosan with low DD degraded more 
quickly. Other studies mentioned that the variation in chitosan degradation can be 
attributed to the differences in the distribution of acetamide groups in the chitosan 
molecule [38, 41]. Differences of this distribution changes inter or intramolecular 
repulsion forces, which influences the viscosity of the chitosan solution [12].  
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1.1.2.5.2 Biocompatibility  
Biocompatibility is one of the most attractive characteristics of chitosan. For 
example, the role of chitosan is not changed by host medium conditions and there are 
no any undesirable local or systemic effects have been recorded or observed due to 
changes in function of chitosan. In spite of the living tissues, including the skin, 
ocular membranes and the nasal epithelium showed real acceptance or well tolerated 
to chitosan. Biocompatibility characteristics also depend on the property of the origin 
of chitosan such as natural source, method of preparation, molecular weight (Mw), 
and DD [12]. 
 
1.1.2.5.3 Toxicity  
Chitosan has very low toxicity when compared with other natural 
polysaccharides. Chitosan showed lethal dose LD50 around 16 g kg 
-1
, very close to 
the value obtained for salt and glucose carried out in the laboratory by in vivo 
toxicity assays [42]. In an earlier study, it was found that the toxicity of chitosan is 
strongly correlated with the DD value. It is reported that chitosan with DD values 
higher than 35% exhibited low toxicity while chitosan with DD value under 35% 
showed dose-dependent toxicity [34]. 
 
1.2 Previous Studies on Modification and Applications of Chitosan  
This section presents the previous studies and survey of the relevant literature 
on the chemically modified chitosan and its applications.  
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1.2.1 Chemically Modified Chitosan 
Chemically modified chitosan has been extensively explored and can be 
considered as the most important method to improve the water solubility of chitosan 
by adding some hydrophilic functional group [43, 44]. The synthetic methods of 
chitosan derivatives reported in the literature falls under one of the three categories; 
N-alkylation, N and/or O acylation and grafting of chitosan.  
 
1.2.1.1 Alkylated Derivatives of Chitosan  
N-alkylated chitosan has been prepared by reacting aldehydes or ketones (the 
Schiff reaction) with the amino groups of chitosan. Then addition of borohydride 
NaBH4 or sodium cyanoborohydride NaBH3CN to reduce imines formed to amines 
as shown in Scheme 1.1 [44 - 46]. It has also been reported that N-alkylated chitosan 
could be obtained by the reaction of alkyl bromide [47] or alkyl iodide [48] with 
amino groups of chitosan, leading to quaternary ammonium formation as shown in 
Scheme 1.2. Domard et al. [49] used this approach to generate a wide pH range of 
water soluble cationic derivatives.  
 
Scheme 1.1: N-alkylation of chitosan using reductive amination approach 
 
Scheme 1.2 Quaternization of chitosan with methyl iodide 
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1.2.1.2 Acylation Derivatives of Chitosan 
Derivatization by acylation has more synthetic pathways compared to N-
alkylation because hydrophobic groups can react with N or O atoms or to both atoms 
at the same time. Aranaz et al. [45] reported that the derivatization of chitosan by a 
hydrophobic group is formed via an ester bond that can be considered as the 
enzymatic actions. They noted that the chitosan derivatives were randomly 
distributed along the chain, through alkylation or acylation under homogeneous 
conditions. Various works were successful in the preparation of N-acylated 
derivatives of chitosan through the anhydrides, acid chlorides interaction with the 
amino groups of chitosan as shown in Scheme 1.3. 
 
 
Scheme 1.3: N-acylated derivatives of the chitosan formed through the anhydrides, 
acid chloride interaction 
 
 
 In the preparation of O substituted derivatives, it is necessary to keep the amino 
group in positive charge thus it works well in an acidic solution. The activity of 
amino groups is higher than the hydroxyl groups, consequently amino groups are 
blocked prior to O acylation, such as in the reactions with acid chlorides in methane 
sulfonic acid as shown in Scheme 1.4 [50]. N, O acylated chitosan reported in prior 
works followed by steps procedure, the first step chitosan O acylation by blocking 
amino groups. The second step involves protection of amino groups removed and 
continued with N-acylation synthesis [45, 51, 52]. Riva et al. [53] and Aranaz et al. 
[45] described the synthesis of N; O acylated chitosan compounds in their reviews. 
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They refer to various methods that have been used to prepare hydrophobic 
derivatives of chitosan by the combination of hydrophobic groups into chitosan 
chains.  
 
 
Scheme 1.4: N, O acylated chitosan by the combination of hydrophobic groups 
 
 1.2.1.3 Thiolation of Chitosan 
Anionic charge can be introduced to the basic structure of the chitosan 
polymer, by the reaction of chitosan with 2-sulfobenzoic acid anhydride as shown in 
Scheme 1.5 [54]. Jayakumar [55] reported the chemical modification of chitosan 
with sulfate produced novel bifunctional materials that are promising for biomedical 
applications. 
 
 
Scheme 1.5: N sulfonation of chitosan with 2-sulfobenzoic acid anhydride 
 
  
1.2.1.4 Grafting of Chitosan  
Many studies have been carried out on the grafting of polysaccharide based 
materials to improve properties for the biomedicine and environmental field of 
applications [56, 57]. Several investigations have been reported on the study of 
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grafting natural polymers by using radiation for example as reported by Jaafar et al. 
[58] and Pengfei et al. [59]. Enzymatic grafting in several previous works described 
some advantages of synthesis and modification of polymers by using enzymes [60]. 
Ilyina et al. [61] reported that enzymatically modified polymers such as partially 
hydrolyzed chitosan can be obtained with similar biochemical properties compared 
to chitosan. Chitosan has also been grafted through the addition of cationic 
polymerization as reported by Yoshikawa et al. [62] They have performed grafting 
reaction by introducing poly (isobutyl vinyl ether) and poly(2-methyl-2-oxazoline) 
cation onto the amino groups in the chitosan. Recently, grafting of vinyl monomers 
through free radical initiation has attracted the interest of several researchers. This 
approach offered wider options with new structures and preferred properties. Sun et 
al. [63] used ammonium persulphate (APS) as an initiator in an aqueous solution to 
prepare carboxymethyl chitosan grafted methacrylic acid. Similarly, Xie et al. [64] 
succeeded in producing hydroxypropyl chitosan grafted methacrylic acid as shown in 
Scheme 1.6, which exhibited more improvement in water solubility. 
 
Scheme 1.6: Graft copolymerization of methacrylic acid on hydroxypropyl chitosan. 
 
Sun et al. [65] used APS initiator to graft copolymerization of maleic acid 
sodium (MAS) onto carboxymethyl chitosan and hydroxypropyl chitosan and 
reported that the reaction conditions played a critical role in the grafting 
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copolymerization. The polymerization of aniline was obtained by the reaction of 
aniline in the presence of APS with chitosan. In this reaction (Scheme 1.7) the 
polyaniline side chains are bonded with the chitosan amino groups [66]. 
 
 
Scheme 1.7 Reaction of chitosan in aqueous acidic medium with using APS as 
initiator [66] 
 
Graft copolymerization of vinyl monomers onto chitosan is also carried out 
using redox initiator systems, such as ceric ammonium nitrate (CAN) and potassium 
persulphate (KPS). This approach was reported for the first time in 1958 by Mino 
and Kaizerman. [67] They employed a ceric ion redox initiating system to achieve 
copolymer grafting. After that, this approach witnessed magnificent development 
[68] especially in the case of cellulose [69] and starch [70]. Usually, this method 
produced grafted copolymers with medium to the high molecular weight that are 
spaced along the backbone of the polysaccharide [69]. 
In previous studies, some organic compounds were reacted with chitosan, 
such as amino acid and amino acid derivatives, aniline, phenol, ether and 
heterocyclic to modify chitosan. Layek and Singh [71] synthesized n-acetylamino 
and amino acids through coupling reaction of mediated carbodiimide which can be 
used in gene treatment. Zhang et al [72] introduced an oral delivery method of 
insulin by using N-octyl-N-arginine chitosan micelles. Yamada [73] has grafted 
hexyloxyphenol onto chitosan by using an enzymatic method. Yang and Yuan [74] 
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synthesized chitosan hydroxyl azacrown ether from the reaction of hydroxyl 
azacrown ether with epoxy-activated chitosan. Many heterocyclic compounds have 
been reacted with chitosan as reported by Badawy [75], such as heterocyclic 
aldehydes containing 3-pyridine carboxaldehyde, 5-methylfuran-2-carbaldehyde, 
furan-2-carbaldehyde and benzo[d] (1,3). The various techniques to prepare chitosan 
derivatives are shown in Figure 1.3 [76]. 
 
 
Figure 1.3: Techniques for derivatization of chitosan [76] 
 
1.3 Applications of Chitosan 
Chitosan and its derivatives have different practical properties, which make 
them appropriate for many applications such as in agriculture, food, wastewater 
management, cosmetics, fiber and biomedicine [7, 9]. The wide variation of chitosan 
molecular weights and degree of deacetylation, give opportunities to use it in 
different cosmetic fields such as skin care, water-resistance, sun protection, 
deodorants and hair care [5, 25]. Chitosan is also used for biomedicine applications; 
clinical studies have found 3-6 grams per day of chitosan can be used with no 
16 
 
adverse effects [9, 64]. Therefore, chitosan attracts lots of attention for the 
pharmaceutical formulation and different medical applications in topical and ocular 
applications, implantation or injection focusing on its biocompatible, absorption-
enhancing, controlled release and bioadhesive properties [5]. Furthermore, chitosan 
can be considered as biodegradable, metabolized by some human enzymes, such as 
lysozyme and bioadhesive [77]. Carreno-Gomez [78] reported that chitosan 
extensively used for oral and intranasal delivery parenteral drug delivery. Chitosan 
has been used as starting material for man-made fibers, filament, powder, granule, 
sponge, absorbable sutures in medical products, composite with cotton or polyester 
and wound dressing materials. It could be considered for skin replacement [79] and 
antitumor effect through the proliferation of cytolytic T-lymphocytes [1, 32].  
Chitosan can attach itself to fat in the stomach before it is digested, and it has 
no calorie value, making it good fat trapper for a weight loss products [1, 7]. 
Additionally chitosan and its derivatives have been used in the large area of 
biological fields such as an antibacterial, antifungal agent, to suppress viral infections 
in various biological systems, plants, animals and humans. Chitosan is also used for 
wound dressing materials [1, 7, 22, 23]. 
 
1.3.1 Anticancer Properties 
Chitosan has direct effects on cancer cells by interfering with cell 
metabolism, stop cell generation, or stimulate cell apoptosis. It plays antitumor role 
by developing the resistant and protections of body functions. Many previous works 
in vitro and in vivo suggested that chitosan is very appropriate for complementary 
antitumor for drug and drug delivery applications [80, 81]. These studies discovered 
the significant changes in the antitumor activity of chitosan nanoparticles from 
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variable manufacturers and the quality of chitosan nanoparticles for particular cancer 
cell [82]. Maeda and Kimura [80] reported that chitosan with low molecular weight 
and chitosan oligosaccharide successfully stopped growing cancer cells in Sarcoma 
180 - bearing mice. Torzsas et al. [81] have established that a diet including chitosan 
can decrease the growth of the cells containing precancerous lesions especially in 
colon cancer caused by azomethane compounds. In an other study, it was found that 
inhibition rates for different types of cancer cell lines (23 % of liver SMMC-7721 
cells, 27 % of Hela cells of cervical cancer, 7721 cells, 29 % of gastric cancer BGC-
823 cells 23 % on liver SMMC), and as high as 55 % of breast cancer MCF-7 cells, 
when treated with 500 mg L 
-1
 chitosan nanoparticles [83].  
Nanoparticles of carboxymethyl chitosan with high toxicity can be grafted 
from doxorubicin/methoxy polyethylene glycol (PEG). These nanoparticles have 
been found to stop the distribution of cancer cells effectively [84]. In addition, 
nanoparticles of paclitaxel chitosan have also exhibited sustained release influence 
with good encapsulation percentage of 94.0% ± 16.73% [85]. Qi et al. [86] have 
applied high surface charged nanoparticles of chitosan to human hepatoma BEL7402 
cells in vitro and found that dose and time correlation with anticancer activity. 
Hosseinzadeh et al, [87] prepared nanoparticles of gemcitabine-loaded via an ionic 
gelation technique, by using Pluronic RF-127 with chitosan nanoparticles as a carrier 
of cytotoxicity on HT-29 colon cancer cell line and found the inhibition of cancer 
cell on HT-29 colon carcinoma cell. Similarly, chitosan–silica hollow nanospheres 
were studied (CS–SiO2 HNPs) for breast tumor cells MCF-7 treatment in vitro and in 
vivo environments with high therapeutic effectiveness [88]. Ignacak et al. [89] 
reported the microcrystalline structure inhibition of Ehrlich ascites tumor (EAT) 
cells. Huang et al. [90] reported that cytotoxicity on human lung carcinoma cell line 
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A549 (in vitro) showed insignificant effect when molecular weight of chitosan is 
decreased. Jiang et al. [91] confirmed that tailored chitosan can stop cell production 
and make apoptosis in MCF-7 breast cancer cell line. Dou et al. [92] found that 
oligochitosan effectively contribute to the apoptosis of HL-60 and similar behavior 
has been observed by Xu et al. [93] for chitooligosaccharides when used for human 
hepatocellular carcinoma cells (SMMC-7721 cells). Kumar et al. [94] studied the 
anticancer and antimicrobial effect of a new chitosan thymine conjugate prepared via 
acylation reaction between chitosan and thymine-1-yl-acetic acid and reported that 
the chitosan thymine conjugate considerably decreased the production of tumorous 
human liver hepatic cellular carcinoma cell line HepG2 cells with non-cytotoxic 
effect. Positive results of using chitosan as anticancer material have been reported by 
Hossain and Takahashi [95] and Hwang et al. [96] for improving the apoptosis in the 
human colon adenocarcinoma, HT-29 cells and prevent tumor of mouse monocyte-
macrophage, RAW 264.7 cell line respectively. It has also been used for bladder 
cancer [97] and colon cancer [98]. Yamada and Clark [99] investigated the effect of 
chitosan on the Ehrlich ascites tumor (EAT) cells via nucleosomal DNA obliteration. 
Chitosan has also been used for prevention as proposed by Shen et al. [100]. They 
showed that chitosan has negative influence on the increase of HepG2 cells and 
destroys cancer cell growth in HepG2-carrier mice.  
The amino group in chitosan under acidic medium is responsible for the 
mucoadhesive properties and increase the residual time at the absorption site. This 
makes chitosan nanoparticles an effective carrier for the oral absorption of drugs 
[101, 102]. Ringdorf [103] introduced the concept of using polymer nanoparticles for 
delivering small molecule drugs to their site of action in 1975. Based on this concept, 
several works successfully applied to use chitosan-anticancer drug conjugates, such 
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as doxorubicin conjugated glycol chitosan (DOX-GC) with a cis-aconite spacer [104] 
and n-lauryl–carboxymethyl which was used as carrier for hydrophobic cancer drugs 
[105].  
The chitosan-based nanoparticles were found to accumulate preferentially in 
the tumor tissue known as EPR (enhanced permeability and retention) effect [105]. 
These chitosan byproducts have the capacity to solubilize taxol micelles to be 
therapeutically useful. Another chitosan-based polymeric micelle for taxol delivery 
in cancer therapy has been tested by Zhang et al. [106]. They obtained new N-alkyl-
O-sulphated chitosan that could be considered as useful taxol for drug carrier. N-
succinyl-chitosan derivatives conjugated have also shown good antitumor activities 
with mitomycin C (MMC) [107]. These chitosan-based conjugates were also proven 
to have good action against murine leukemia (L1210 and P338), B16 melanoma, 
murine liver metastatic tumor (M5076, Sarcoma 180 solid tumor) and murine hepatic 
cell carcinoma (MH134). Tan et al. [108] reported interesting results of chitosan as 
anticancer drug conjugates. This is attributed to the excellent properties of chitosan, 
and it use as nanoparticle for drug delivery systems. 
 
1.3.2 Antimicrobial Activity of Chitosan 
Many antimicrobials materials such as sulfite, benzoate, sorbate were 
employed as reliable stabilizers to control microbial contaminants and risks in food 
manufacturing for decades [109]. These synthetic materials are not considered 
healthy foods; consumers are looking for safer and preferably natural antimicrobials. 
Chitosan has attracted much attention as the natural substitution material and offers a 
wide variety of antimicrobial activity including bacteria, yeast, and fungi [110]. 
Moreover, it exhibits more advantages relative to other natural antimicrobials, such 
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as better antimicrobial properties, a wider range of the behavior spectrum, greater 
killing extent and minor mammalian cells toxicity [110].  
Several mechanisms can explain the antimicrobial activity of chitosan. 
Nikaido [111] reported that the gram-negative bacteria are more resistant to 
amphiphilic and lipophilic inhibitors compared with the gram-positive bacteria. 
Chitosan cannot pass through the external layer of gram-negative bacteria. However, 
the positive charge of the chitosan molecule which comes from the amino group at 
C-2 below its pKa (pH 6.3), creates the polycationic structure of chitosan. This 
polycationic structure interacts with the predominantly anionic components of the 
gram-negative surface such as proteins and lipopolysaccharides. According to 
Helander et al. [112] the polycationic chitosan binding of outer membrane (OM) of 
gram-negative bacteria caused to interrupt and loss barrier function of the OM. The 
antibacterial activity of chitosan obtained from the interface of chitosan’s positive 
charges with the macromolecules negative charges at the bacterial cell surface, which 
changes the cell permeability [113, 114]. 
Sudarshan et al. [114] studied the mechanism of antibacterial activity of 
chitosan by referring to the binding of the amino group of chitosan to the surface 
components of bacteria. Chitosan cause cell death due to leakage of intracellular 
components at lower concentrations (0.1 mg mL
-1
). Additional coating of the 
bacterial surface can be achieved at a higher level (2.0 and 5.0 mg mL
-1
). This effect 
can stop the leakage of intracellular components as well as to impede mass transfer 
across the cell barrier [115]. Helander et al. [112] reported experimental confirmation 
about the mechanism of antibacterial activity of chitosan namely E. coli, P. 
aeruginous and S. Typhimurium by using electron microscopy. It is clear that 
chitosan disrupts the barrier properties of the outer membrane of gram-negative 
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bacteria. The electron micrographs demonstrated that site action of the chitosan is at 
the outer membrane (OM) of bacteria. Similar experimental results were stated by 
Coma et al. [115] for the bactericidal activity of chitosan on bacteria like L. innocua. 
They attributed the action to the interface of positively charged of chitosan with the 
negatively charged of the bacterial cell surface. 
Previous studies on the activity of chitosan with biological membranes cannot 
sufficiently explain the electrostatic interactions of the protonated amino groups at 
low pH [116]. Another study mentioned that hydrophobic interactions have an 
important role in the polysaccharide action. In the investigation, the effect of pH and 
molecular weight of chitosan showed that increasing molecular weight (213 kDa) 
and decreasing pH can lead to disruption of the membrane [117]. The ionization of 
the amino groups of chitosan increases the antimicrobial activity of chitosan with 
decreasing pH to below 6 [10, 19, 23]. At pH 7, unmodified chitosan is not 
antimicrobial active because it does not dissolve and does not contain any positive 
charge [21, 118]. The antimicrobial activity of water-soluble chitosan derivatives 
depended on the degree of deacetylation and the substituted group [118]. 
A study has shown that anti-fungal and bactericidal activities of chitosan can 
be due to the ability of chitosan to interrupt the inner and outer membranes of the 
cells [119]. The role of electrostatic, hydrophobic and hydrogen bond in the 
interactions between chitosan and three different lipids has been investigated using 
Langmuir films to mimic the interaction between chitosan and bacterial membranes 
[120]. The results showed that the effect of chitosan on dipalmitoyl 
phosphatidylglycerol (DPPG) can be negligible [120]. This effect was found to 
decrease with increasing pH, due to the charge-mediating action of chitosan, whereas 
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pH did not affect the cholesterol monolayers where interactions occur mainly via 
hydrogen bonding.  
 
1.3.2.1 Determination of Chitosan Antimicrobial Activities 
Antimicrobial activities of chitosan were obtained by three methods, namely 
agar dilution, broth microdilution and disk diffusion. These techniques are 
recommended by Clinical and Laboratories Standards Institute (CLSI) as standard 
methods in vitro, to determine the sensitivity of bacteria applied as antimicrobial 
agents (CLSI, 2009; CLSI, 2009) [121]. Disk diffusion technique tests a large 
number of antimicrobials separately in a comparatively easy and cheap way and the 
results can be considered as qualitative since it can only show the sensitivity of 
antimicrobials against the bacteria tested, which is defined as susceptible, 
intermediate, and resistant that is associated with diameter of inhibition region. The 
disk diffusion technique can not determine the minimum inhibitory concentration 
(MIC), also it is hard to test the susceptibility of fastidious and slow-growing 
bacteria [122]. Besides, it is labor-intensive and time-consuming, in the same manner 
as other agar-based techniques [123]. 
Many reported works used disk diffusion to define the antimicrobial activities 
of chitosan [123-126]. Moreover, this technique is not always dependable for 
determining the antibacterial activity of natural antibacterial due to the polarity of the 
natural compounds that can affect the diffusion of compounds onto the culture 
medium [15]. 
Agar dilution technique is a quantitative susceptibility testing method using 
two-fold dilutions of an antibiotic made in Mueller-Hinton agar (MHA) medium and 
after that bacterial suspensions were inoculated on MHA [121].  
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The advantages of this method are that it can investigate the weaknesses of a 
number of bacteria in one plate and can test the fastidious microorganisms, and the 
agar can upkeep the bacteria growth sufficiently at the same time. Moreover, the agar 
dilution method is not usually used in most microbiology laboratories as it is costly, 
need intensive work and time-consuming. Broth microdilution technique is also a 
quantitative method normally employed in medical test centers and laboratories. This 
technique can also investigate the effects of numerous antimicrobials at the same 
time. Additionally, this method is highly saving in media usage, requires a small 
amount of testing sample and less time-consuming compared to the agar-based 
technique [127].  
Both agar dilution and broth microdilution techniques can be applied to 
define MIC value. Earlier work reported that broth microdilution showed less MIC 
values than agar dilution for 47 gram-negative bacteria [127]. However, many 
studies have been done to compare the agar dilution and broth microdilution in 
antibiotic susceptibility testing and found a real association between them [127, 128]. 
Luber et al. [127] suggested that the broth microdilution method would be suitable 
and fast screening method for MIC determination as compared to the other methods. 
Based on a rather recent study, broth microdilution method can be recommended as a 
quick screening method for MIC determination. However, presently there are few 
studies on the evaluation of methodologies used for measuring the antimicrobial 
activity of chitosan, indicating that continuation of our study is needed for future 
work. However, in this research, MIC was determined by the broth microdilution 
method.  
A broad range of MIC for chitosan to be used as antimicrobial material 
ranging from 0.005 % to 1.5 % (w/v) [129, 130, 131] has been reported. High 
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concentration of chitosan (1-1.5 %) showed complete inhibition of S. aureus after 
two days of incubation [132], while in another work chitosan concentrations lower 
than 0.005 % was enough to achieve deactivation of S. aureus [131]. To hamper the 
growth of B. cereus 0.02 % of chitosan was considered necessary as stated by 
Simpson et al. [132], Daramdji and Izumimoto [133] reported that for E. coli 
inhibition 0.1 % concentration of chitosan in meat protection, while another work 
reported that 0.0075 % of chitosan was adequate to stop the intensification of E. coli 
[131]. Moreover, at pH 5.5 chitosan with concentrations of 0.5 or 1 % can totally 
deactivate the growth of E. coli [134]. Besides, No et al. [130] reported that the 
growth of L. monocytogenes and V. para haemolytic us were completely inhibited by 
applying 0.1 % concentration of chitosan with molecular weight of 746 kDa and 470 
kDa, respectively. 
 
1.3.2.2 Factors Affecting the Antimicrobial Activity  
Several factors affect the antimicrobial activity of different chitosans. These 
factors include two categories, i.e., intrinsic and extrinsic factors, such as Mw, DD, 
concentration, viscosity, solvent, pH, test strains, temperature and metal ions [3]. 
Moreover, the variation of application methodologies is an additional important 
factor that changed the results of chitosan antimicrobial activity.  
 
1.3.2.2.1 Intrinsic Factors  
In spite of numerous investigations the intrinsic and extrinsic factors 
influencing the activity of chitosan in antimicrobial applications, it is still a great 
challenge to identify the effect of the DD or molecular weight on this activity. For 
example, chitosan showed greater antimicrobial competence against gram-negative 
